UK Breast Cancer Group is a forum for Clinical and Medical Oncologists

2023 Evaluation Meeting Questionnaire

Many thanks for your attendance at the meeting. To enable us to process your CPD certificate and to plan future meetings, we would be very grateful if you could complete questionnaire below.

Evaluation Questionnaire
* marks a mandatory field

I attended the meeting on both Friday 17th and Saturday 18th November 2023

I attended the meeting only on Friday 17th November 2023

I attended the meeting only on Saturday 18th November 2023

About You

About the UKBCG Meeting

Learning Outcomes

Following the meeting:

  • Participants will understand the potential role of new and emerging management options for different stages of breast cancer
  • Participants will be informed of recent, and in some cases practice-changing, data across breast cancer management
  • Participants will share best practice for the management of patients with breast cancer

Not at all
Completely
1
2
3
4
5
Poor
Excellent
1
2
3
4
5
Highly Unlikely
Highly Likely
1
2
3
4
5

5. How would you rate the educational value of each of the following sessions?
Below is a list of sessions from the annual UKBCG meeting. For each, please give a rating between 1 and 5.

Friday 17th November

Session 1: Update of 2023

Translational Research

Stephen Johnston

Poor
Excellent
1
2
3
4
5

Early Breast Cancer Update

Alicia Okines

Poor
Excellent
1
2
3
4
5

Radiotherapy Update

Mukesh Mukesh

Poor
Excellent
1
2
3
4
5

Session 2: Primary and Metastatic National Breast Cancer Audits

David Dodwell

Poor
Excellent
1
2
3
4
5

Session 3: Case Discussions: Early Breast Cancer

Chair: Judy King; Panel: Jennifer Glendenning, Fharat Raja, Richard Simcock, Ashutosh Kothari

Poor
Excellent
1
2
3
4
5

Session 4: Updates Around Immunotherapy

National Advance in mRNA Vaccines for Cancer

Lennard Lee

Poor
Excellent
1
2
3
4
5

Gut Biome and Immunotherapy

Melissa Phillips

Poor
Excellent
1
2
3
4
5

Immuno Toxicity: Long Term Toxicity and Newer Insights into Toxicity Management

Amna Sheri

Poor
Excellent
1
2
3
4
5

Session 5: Heart, Lungs and Bones

Pulmonary Toxicity of New Breast Cancer Drugs

Colm Leonard

Poor
Excellent
1
2
3
4
5

Update on Bones

Caroline Wilson

Poor
Excellent
1
2
3
4
5

Cardio-oncology: Toxicity and New Guidlines

Alexander Lyon

Poor
Excellent
1
2
3
4
5

Saturday 18th November

Session 6: Controversial Topics in Breast Radiotherapy

Breast Cancer UK Outcome Data

Carolyn Taylor

Poor
Excellent
1
2
3
4
5

Debating Breast Radiotherapy

Shaveta Mehta, Mukesh Mukesh, Carolyn Taylor, Duncan Wheatley

Poor
Excellent
1
2
3
4
5

Session 7: New Drug Approvals in Breast Cancer

Caroline Michie

Poor
Excellent
1
2
3
4
5

Session 8: Case Discussions: Metastatic Breast Cancer

Chair: Dan Rea; Panel: Iain Macpherson, Andrea Stevens, Matthew Winter

Poor
Excellent
1
2
3
4
5

Session 9: Update on Metastatic Breast Cancer

Mark Verrill

Poor
Excellent
1
2
3
4
5

Session 10: Junior Doctor Abstracts

Chairs: Duncan Wilkins & Susan Cleator

Poor
Excellent
1
2
3
4
5

Workforce Update

Carlo Palmieri

Poor
Excellent
1
2
3
4
5

Not at all
Greatly
1
2
3
4
5
Decoration Image